QQ客服 官方微博 反馈留言

	HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers
	Hua, Feng; Guo, Yonglu; Sun, Qiang; Yang, Leizhou; Gao, Fang
刊名	THORACIC CANCER
	2019
卷号	10期号:4页码:601-606
关键词	CYP2A13 genetic polymorphism HapMap Project lung cancer susceptibility
DOI	10.1111/1759-7714.12954
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4529861
专题	山东大学
作者单位	Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Dept Thorac Surg, Jiyan Rd 440, Jinan 250117, Shandong, Peoples R Chi
推荐引用方式 GB/T 7714	Hua, Feng,Guo, Yonglu,Sun, Qiang,et al. HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers[J]. THORACIC CANCER,2019,10(4):601-606.
APA	Hua, Feng,Guo, Yonglu,Sun, Qiang,Yang, Leizhou,&Gao, Fang.(2019).HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers.THORACIC CANCER,10(4),601-606.
MLA	Hua, Feng,et al."HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers".THORACIC CANCER 10.4(2019):601-606.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。